These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 3911723)

  • 1. Effects of vitamin D. A comparison of 1 alpha OHD2 and 1 alpha OHD3 in rats.
    Sjödén G
    Acta Orthop Scand Suppl; 1985; 217():1-84. PubMed ID: 3911723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of 1 alpha OHD2 on bone tissue. Studies of 1 alpha OHD2 and 1 alpha OHD3 in normal rats and in rats treated with prednisolone.
    Sjödén GO; Johnell O; DeLuca HF; Lindgren JU
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):564-8. PubMed ID: 6332445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
    Hughes MR; Baylink DJ; Jones PG; Haussler MR
    J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antirachitic activity of 1 alpha-hydroxyergocalciferol and 1 alpha-hydroxycholecalciferol in rats.
    Sjöden G; Lindgren JU; DeLuca HF
    J Nutr; 1984 Nov; 114(11):2043-6. PubMed ID: 6333501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recognition of 25-hydroxyvitamin D2 and D3 by a new binding protein based 25-hydroxyvitamin D assay.
    Su Z; Slay BR; Carr R; Zhu Y
    Clin Chim Acta; 2013 Feb; 417():62-6. PubMed ID: 23266769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Actions of vitamins D2 and D3 and 25-OHD3 in anticonvulsant osteomalacia.
    Christiansen C; Rodbro P; Munck O
    Br Med J; 1975 May; 2(5967):363-5. PubMed ID: 165857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of prednisolone on kidney calcification in vitamin D-treated rats.
    Sjöden G; Lindgren U
    Calcif Tissue Int; 1985 Dec; 37(6):613-6. PubMed ID: 3937584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of vitamin D and its metabolites on calcium transport in the diabetic rat.
    Schneider LE; Omdahl J; Schedl HP
    Endocrinology; 1976 Sep; 99(3):793-9. PubMed ID: 182468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of 1 alpha-hydroxycholecalciferol and of a varying phosphorus requirement on mineral metabolism in chronic renal insufficiency].
    Blazheevich NV; Fernándes R; Isaeva VA; Pereverzeva OG; Alekseeva IA
    Vopr Med Khim; 1980; 26(1):13-23. PubMed ID: 7368619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D physiology and some clinical aspects of the vitamin D endocrine system.
    Favus MJ
    Med Clin North Am; 1978 Nov; 62(6):1291-317. PubMed ID: 216858
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic use of vitamin D, its derivatives and their analogs].
    Vagneur JP; Argemi B
    Diabete Metab; 1982 Mar; 8(1):65-7. PubMed ID: 6980150
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparative therapeutic effects of vitamin D3 and its derivatives on experimental renal osteodystrophy.
    Fukushima M; Niki R; Ohkawa H; Shimizu T; Matsunaga I; Nakano H; Takagaki Y; Nishii Y; Okano K; Suda T
    Endocrinology; 1980 Jul; 107(1):328-33. PubMed ID: 6247140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absorption, dosage, and effect on mineral homeostasis of 25-hydroxycholecalciferol in premature infants: comparison with 400 and 800 IU vitamin D2 supplementation.
    Hillman LS; Hollis B; Salmons S; Martin L; Slatopolsky E; McAlister W; Haddad J
    J Pediatr; 1985 Jun; 106(6):981-9. PubMed ID: 3889260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of osteoinduction by vitamin D metabolites in rachitic host rats.
    Atkin I; Dean DD; Muniz OE; Agundez A; Castiglione G; Cohen G; Howell DS; Ornoy A
    J Bone Miner Res; 1992 Aug; 7(8):863-75. PubMed ID: 1442201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha-hydroxyvitamin D2 is less toxic but not bone selective relative to 1alpha-hydroxyvitamin D3 in ovariectomized rats.
    Weber K; Goldberg M; Stangassinger M; Erben RG
    J Bone Miner Res; 2001 Apr; 16(4):639-51. PubMed ID: 11315991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The action of vitamin D metabolites (25 OHD3--12,5 (OH)2D3--24.25 (OH)2D3--25.26 (OH)2D3) on vitamin D deficient rats.
    Queille ML; Miravet L; Bordier P; Redel J
    Biomedicine; 1978; 28(4):237-42. PubMed ID: 737274
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of parenteral administration of 25-hydroxycholecalciferol and 1 alpha-hydroxycholecalciferol on the mineral concentrations in the blood of cows in late pregnancy].
    Zepperitz H; Schwabe H
    Berl Munch Tierarztl Wochenschr; 1993 Jun; 106(6):183-8. PubMed ID: 8343104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D: the vitamin and the hormone.
    DeLuca HF
    Fed Proc; 1974 Nov; 33(11):2211-9. PubMed ID: 4372106
    [No Abstract]   [Full Text] [Related]  

  • 20. Metabolism and molecular mechanism of action of vitamin D: 1981.
    DeLuca HF
    Biochem Soc Trans; 1982 Jun; 10(3):147-58. PubMed ID: 7049788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.